Qvents

Qvents

Discussion forum for Pharma Quality events, Regulatory Actions

Warning letters, 483s, Recalls, Import Alerts, Audit observations

CDSCO Not of Standard Quality Drug Alert

The Central Drugs Standard Control Organisation (CDSCO) has published the NSQ (Not of Standard Quality)

FDA Issues Warning Letter to Aspen Bioph

The U.S. Food and Drug Administration (FDA) issued a Warning Letter to Aspen Biopharma Labs

CDSCO Notifies New Online Export NOC Sys

Indian drug regulatory, CDSCO has notified the new online Export NOC system for Unapproved Drugs

FDA Approves Sanofi’s New Hemophilia 

The U.S. Food and Drug Administration (FDA) has approved Sanofi’s Qfitlia (fitusiran) for the treatment

FDA Issues Repeat Warning Letter to Thai

The U.S. FDA issued a warning letter to International Laboratories Corp. (FEI 3006403166) following CGMP

Strides Recall Several Lots of Topical G

Strides Pharma Inc is recalling over 38 lots of Testosterone Gel 1% in the US

Glenmark Recalls Over 1.5 Million Bottle

Glenmark Pharmaceuticals has initiated a recall of over 1.5 million bottles of their ADHD medication,

USFDA Issues Warning Letter to Global Ca

Indian API manufacturer Global Calcium Pvt Ltd was issued a Warning letter by USFDA in

FDA Issues Warning letter to Chinese API

FDA issued Warning letter to two Chinese API manufacturers following for cGMP violations including failing

Timeline for Revised Schedule M Implemen

Health Ministry in India has extended the timeline for implementation of the revised Schedule M